Results 71 to 80 of about 3,281 (174)

Utility and Safety of Romiplostim as an Alternative to Platelet Transfusion for Neonates [PDF]

Thrombocytopenia is a common challenge in the neonatal intensive care unit, traditionally managed with platelet transfusions. However, transfusions are associated with significant risks, including increased mortality and neurodevelopmental impairment ...
Zeno, Rachel N., Lesmana, Harry, Awad, Sara   +2 more
core   +1 more source

A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopenia

Haematologica, 2013
Romiplostim and eltrombopag, the first thrombopoietic receptor-agonists with demonstrated efficacy against immune thrombocytopenia in prospective controlled studies, were recently authorized in most countries for adults with chronic immune ...
Mehdi Khellaf, Jean-François Viallard, Mohamed Hamidou, Stéphane Cheze, Françoise Roudot-Thoraval, François Lefrere, Olivier Fain, Sylvain Audia, Jean-François Abgrall, Jean-Marie Michot, Charles Dauriac, Sophie Lefort, Emmanuel Gyan, Mathilde Niault, Jean-Marc Durand, Laetitia Languille, David Boutboul, Philippe Bierling, Marc Michel, Bertrand Godeau   +19 more
doaj   +1 more source

Successful Management of Immune Thrombocytopenia Presenting with Lethal Alveolar Hemorrhage

Case Reports in Hematology, 2019
Immune thrombocytopenic purpura (ITP) typically presents with bleeding due to immunologic thrombocytopenia. Severe hemorrhage due to ITP is sometimes lethal, and the urgent recovery of platelets is necessary.
Keiki Nagaharu, Masahiro Masuya, Keiki Kawakami, Naoyuki Katayama   +3 more
doaj   +1 more source

Efficacy and safety of high doses of eltrombopag for treating adult immune thrombocytopenia: Results from a multicentre retrospective cohort study

British Journal of Haematology, Volume 209, Issue 4, Page 1937-1940, October 2026.
Salomé Dahan, Stéphanie Guillet, Olivier Fain, Delphine Gobert, Stéphane Cheze, Florent Broca, Bertrand Godeau, Marc Michel   +7 more
wiley   +1 more source

The Cost-Effectiveness of Avatrombopag Versus Eltrombopag and Romiplostim in the Treatment of Patients with Immune Thrombocytopenia in the UK

Journal of Market Access & Health Policy
Background: Thrombopoietin receptor agonists—romiplostim, eltrombopag and avatrombopag—are commonly used as second-line treatments for immune thrombocytopenia (ITP).
Nichola Cooper, Sebastian Guterres, Michał Pochopień, Koo Wilson, Sam James, Mondher Toumi, Anna Tytuła, Carly Rich, Daniel Eriksson   +8 more
doaj   +1 more source

Pragmatic Clinical Trial of Fostamatinib as Second‐Line Therapy in Adult Patients With Immune Thrombocytopenia and Insufficient Response to Prior Therapy: The Fostamatinib FORTE Trial

eJHaem, Volume 7, Issue 4, August 2026.
Amber Afzal, Robert Kribs, Sumit Sawhney, Mohit Narang, Frances Blevins, Robert Numerof, Francois Di Trapani, Sherry Ladha, Ruchika Goel   +8 more
wiley   +1 more source

Refractory autoimmune hemolytic anemia with poor erythropoietic compensation in combined immunodeficiency: A case series

Pediatric Allergy and Immunology, Volume 37, Issue 8, August 2026.
Letizia Baldini, Mattia Moratti, Alessandro Ruggi, Francesco Licciardi, Fraia Melchionda, Maura Fois, Maria Elena Cantarini, Elena Facchini, Veronica Barat, Giovanni Del Borrello, Bruno Fattizzo, Elena Sabattini, Clara Bertuzzi, Riccardo Masetti, Francesca Conti   +14 more
wiley   +1 more source

Neu in der Therapie der chronischen Immun - thrombozytopenie (ITP): Romiplostim ist bisheriger Standardbehandlung überlegen

, 2011
Die Langzeittherapie mit dem TPO-Rezeptor-Agonisten Romiplostim (Nplate®) steigert die Thrombozytenzahlen bei ITP-Patienten und kann die Splenektomie-Rate senken.
Beate Grübler
core   +1 more source

This Is Not a Myeloproliferative Neoplasm…

Pediatric Blood &Cancer, Volume 73, Issue 7, July 2026.
Stephanie Juané Kennedy
wiley   +1 more source

Real-world experience with romiplostim in the management of primary immune thrombocytopenia in Iraqi adult patients

Iraqi Journal of Hematology
BACKGROUND: Low platelet counts resulting from increased platelet breakdown and poor platelet generation are the hallmarks of immune thrombocytopenia (ITP), an autoimmune illness.
Alaadin Sahham Naji, Alhan A. Alkhalidi, Luma Essa Hammodi, Ahmed Mjali   +3 more
doaj   +1 more source